MannKind Corp
MNKD
#4876
Rank
ยฃ1.33 B
Marketcap
ยฃ4.34
Share price
2.73%
Change (1 day)
-16.95%
Change (1 year)

Revenue for MannKind Corp (MNKD)

Revenue in 2025 (TTM): ยฃ0.23 Billion

According to MannKind Corp's latest financial reports the company's current revenue (TTM ) is ยฃ0.23 Billion. In 2024 the company made a revenue of ยฃ0.22 Billion an increase over the revenue in the year 2023 that were of ยฃ0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MannKind Corp from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.23 B4.9%
2024 ยฃ0.22 B45.68%
2023 ยฃ0.15 B89.37%
2022 ยฃ82.46 M47.56%
2021 ยฃ55.88 M16.94%
2020 ยฃ47.79 M-0.58%
2019 ยฃ48.07 M119.04%
2018 ยฃ21.94 M152.55%
2017 ยฃ8.69 M-93.86%
2016 ยฃ0.14 B
2015 N/A
2014 N/A
2013 N/A-100%
2012 ยฃ0.02 M-32.69%
2011 ยฃ0.03 M-46.6%
2010 ยฃ0.06 M
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Halozyme Therapeutics
HALO
ยฃ0.93 B 296.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
ยฃ35.41 B 14,945.74%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Merck
MRK
ยฃ48.18 B 20,370.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ44.57 B 18,836.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
ยฃ46.95 M-80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.09 B 19,909.11%๐Ÿ‡บ๐Ÿ‡ธ USA